Twickenham, United Kingdom

Dominique A Fontanilla

This inventor holds 2 USPTO granted patents. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2013-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dominique A Fontanilla. Retrieved from https://idiyas.com/inventor/dominique-a-fontanilla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Location History:

  • Madison, WI (US) (2013)
  • Twickenham, GB (2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Dominique A Fontanilla

Introduction

Dominique A Fontanilla is an accomplished inventor based in Twickenham, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of selective sigma-1 receptor ligands. With a total of 2 patents, his work focuses on compounds that can potentially treat various medical conditions.

Latest Patents

Fontanilla's latest patents include innovative compounds that provide high affinity binding to sigma-1 receptors in mammals. These compounds exhibit selectivity for the sigma-1 receptor over the sigma-2 receptor. The applications of these compounds are vast, as they can be used to treat conditions involving the sigma-1 receptor, such as addiction, cardiovascular diseases, and various types of cancer, including breast, lung, prostate, ovarian, colorectal, and central nervous system cancers.

Career Highlights

Dominique A Fontanilla is associated with the Wisconsin Alumni Research Foundation, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on therapeutic strategies.

Collaborations

Fontanilla collaborates with notable colleagues, including Uyen B Chu and Abdol R Hajipour, who contribute to his research endeavors.

Conclusion

Dominique A Fontanilla's innovative work in the field of sigma-1 receptor ligands showcases his commitment to advancing medical science. His contributions have the potential to lead to significant breakthroughs in the treatment of various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…